BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3520085)

  • 1. [Use of the hypotensive drug guanfacine in the treatment of patients with hypertension].
    Kravchenko IG; Liashenko MM; Tarnakin AG; Chirkov SN
    Kardiologiia; 1986 Mar; 26(3):41-5. PubMed ID: 3520085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
    Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of arterial hypertension with a single daily dose of guanfacine].
    Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
    Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypotensive and hemodynamic effects of guanfacine in arterial hypertension].
    Erina EV; Beliakova EV; Charyev KhZ; Panfilov VV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(1):63-7. PubMed ID: 2663029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive effect of guanfacine in essential hypertension: a comparison with clonidine.
    Lauro R; Reda G; Spallone L; Anguissola AB
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):81S-82S. PubMed ID: 6994784
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of long-term treatment of essential hypertension with guanfacine.
    Higuchi M; Overlack A; Stumpe KO
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):61S-64S. PubMed ID: 6994780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension.
    Collart F; Staroukine M; Verniory A
    Acta Cardiol; 1985; 40(3):269-76. PubMed ID: 3895792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of single and multiple doses of guanfacine in essential hypertension.
    Zamboulis C; Reid JL
    Clin Pharmacol Ther; 1980 Dec; 28(6):715-21. PubMed ID: 7002428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
    Jerie P; Lasance A
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):279-87. PubMed ID: 7030975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with guanfacine in long-term treatment of hypertension.
    Jerie P
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):37S-47S. PubMed ID: 6994777
    [No Abstract]   [Full Text] [Related]  

  • 12. Guanfacine: effects of long-term treatment and withdrawal.
    Reid JL; Zamboulis C; Hamilton CA
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):183S-188S. PubMed ID: 6994774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of hypertension with guanfacine alone and in combination therapy.
    Seedat YK
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):65S-66S. PubMed ID: 6994781
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the hypotensive effect of guanfacine].
    Adamska-Dyniewska H; Dziekański S
    Pol Arch Med Wewn; 1988 Jun; 79(6):289-95. PubMed ID: 3078198
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive effects and plasma levels of guanfacine in man.
    Safar ME; Loria Y; Weiss YA; Boutier JR
    J Clin Pharmacol; 1982; 22(8-9):385-90. PubMed ID: 6752213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
    Rosenthal J; Jäger H
    MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis.
    Ikeda T; Gomi T; Yuhara M; Sakurai J; Nakayama D
    Clin Pharmacol Ther; 1988 Mar; 43(3):278-82. PubMed ID: 3278821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.
    Manhem P; Hökfelt B
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):109S-114S. PubMed ID: 6994763
    [No Abstract]   [Full Text] [Related]  

  • 19. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
    Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G
    Arzneimittelforschung; 1980; 30(6):1005-7. PubMed ID: 6998487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
    Dvorák I; Podrouzková B; Kocourková J; Kubesová H; Spác J; Nĕmcová H; Blaha M
    Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.